Nav: Home

UK researchers publish study highlighting use of 10x Genomics' GemCode™ technology

March 03, 2016

PLEASANTON, Calif.--March 3, 2016--10x Genomics, a company focused on improving and broadening the application of genomic information across healthcare and other industries, today announced the publication of a study that was enabled by the company's GemCode™ technology platform, a powerful new approach that allows researchers to discover previously inaccessible genomic information. The research analyzed the biomedical consequences of adult humans with gene knockouts, and the impact of one specific knockout on genetic recombination patterns. The study, titled "Health and Population Effects of Rare Gene Knockouts in Adult Humans with Related Parents," has been published in the Mar. 3 issue of the journal Science.

The GemCode technology platform was used to perform an in-depth analysis of an inactive gene, or 'knockout', in PRDM9, a gene that was thought to be essential to produce functional eggs or sperm. Phased genome sequencing was performed using 10x's Linked-Read approach in samples from a healthy mother with the PRDM9 knockout, her healthy son and controls. Results demonstrated PRDM9 redundancy in humans and suggested, for the first time, that humans do not require the PRDM9 gene. These results were supportive of the researcher's broader conclusion that only a fraction of genes appear to be essential for human life.

"We were delighted to collaborate with 10x Genomics using molecular phasing to find the recombination sites in the person lacking PRDM9," said Richard Durbin, Ph.D., senior group leader at the Wellcome Trust Sanger Institute and co-author of the study. "With the Linked-Read approach through the GemCode technology platform, we were able to precisely identify recombination events in individual subjects and compare these data with known patterns of recombination - all exactly what we wanted from the technology."

The researchers in this study opted to use the GemCode technology because the microfluidics-based, Linked-Read sequencing technology, built on the system's proprietary platform is the only commercially available sequencing technology that can phase and haplotype human genomes using only nanograms of input DNA. This droplet-based system prepares barcoded libraries for short-read sequencing and computationally reconstructs long-range haplotype and structural variant information.

"This publication and its significant applications underscore the importance of phasing genomes and the unique ability of our technology to study biological events that have been difficult or impossible to obtain previously," said Serge Saxonov, Ph.D., chief executive officer and co-founder of 10x Genomics. "Our GemCode technology provides a new paradigm for whole genome analysis and has the ability to unlock valuable insights into human health."

The study has been published in the Mar. 3 issue of Science.
-end-
About 10x Genomics

10x Genomics meets the critical need for long range, structural and cellular information, with an innovative system that transforms the capability of existing short-read sequencers. Our GemCode platform supports comprehensive genomics and high-throughput single-cell transcriptomics. It enables researchers to discover previously inaccessible genomic information at massive rate and scale, including phased structural variants, phased single nucleotide variants, and dynamic gene expression of individual cells--while leveraging their existing sequencing systems and workflows. For more information, please visit http://www.10xGenomics.com.

About Science Magazine

Science has been at the center of important scientific discovery since its founding in 1880--with seed money from Thomas Edison. Today, Science continues to publish the very best in research across the sciences, with articles that consistently rank among the most cited in the world. The Science family of journals is published by the American Association for the Advancement of Science (AAAS), the world's oldest and largest general science organization. The nonprofit AAAS serves 10 million people through primary memberships and affiliations with some 262 scientific societies and academies.

Contact:

Media Contact
Dan Budwick
Pure Communications, Inc.
(973) 271-6085
dan@purecommunicationsinc.com

Investor Contact
Matt Clawson
Pure Communications, Inc.
(949) 370-8500
matt@purecommunicationsinc.com

10x Genomics

Related Genomics Articles:

Picking up threads of cotton genomics
In Nature Genetics, a multi-institutional team including researchers at the US Department of Energy (DOE) Joint Genome Institute (JGI) has now sequenced and assembled the genomes of the five major cotton lineages.
Progress in unraveling the mystery of the genomics of Parkinson's disease
The International Parkinson Disease Genomics Consortium (IPDGC) has now been in existence for ten years.
New database enhances genomics research collaboration
Sharing datasets that reveal the function of genomic variants in health and disease has become easier, with the launch of a new, open-source database developed by Australian and North American researchers.
Speeding up single-cell genomics research
Time-saving method makes it possible to profile gene regulation in tens of thousands of individual human cells in a single day.
A new vision for genomics in animal agriculture
Iowa State University animal scientists helped to form a blueprint to guide the next decade of animal genomics research.
Genomics could better match treatments to pancreatic cancer patients
Pancreatic cancer is a grim diagnosis, but this new study, the largest of its kind, identifies genomic markers that could increase survival by better matching chemotherapy drugs to patients.
In prenatal testing, 'genomics' sometimes sees what genetic tests can't
One of the first large prospective studies of its kind reveals the potential -- and limitations -- of a new form of genetic testing in pregnancy.
Genomics provide hope for those with 'one in a million' cancer diagnosis
New research has shown that many people with rare cancers can benefit from genomic profiling.
Precision genomics point the way to mutations associated with accelerated aging
Mayo Clinic researchers are using precision genomics to search for undiscovered, inheritable genetic mutations that cause accelerated aging.
Genomics is disrupting the healthcare sector
Affordable, rapid DNA sequencing is causing a revolution in medicine and healthcare globally -- and it's happening now, says Thomas Barlow (Barlow Advisory), the author of the landmark Garvan Global Genomics Report, which launches today.
More Genomics News and Genomics Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.